Iradimed (IRMD) Current Assets (2013 - 2026)

Iradimed (IRMD) has reported Current Assets for 14 consecutive years, with $86.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 12.08% year-over-year to $86.7 million in Q2 2026; TTM through Jun 2026 was $86.7 million, a 12.08% increase from a year earlier, with the FY2025 full-year figure at $81.2 million, up 7.92% from the prior year.
• Current Assets was $86.7 million for Q2 2026 at Iradimed, roughly flat from $86.4 million in the prior quarter.
• Over five years, Current Assets peaked at $86.7 million in Q2 2026 and troughed at $61.3 million in Q1 2023.
• A 5-year average of $74.7 million and a median of $74.7 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets retreated 6.44% in 2023 and grew 17.27% in 2024, its largest moves.
• Over 5 years, Current Assets stood at $77.5 million in 2022, then dropped by 1.92% to $76.0 million in 2023, then decreased by 1.0% to $75.2 million in 2024, then climbed by 7.92% to $81.2 million in 2025, then grew by 6.8% to $86.7 million in 2026.
• The last three Current Assets figures came in at $86.7 million (Q2 2026), $86.4 million (Q1 2026), and $81.2 million (Q4 2025), per Business Quant data.